Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vyth

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinomaG C de Gast, H J Klümpen, F A Vyth-Dreese, et al.
Immunology|October 10, 1998
Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphomaF A Vyth-Dreese, H Boot, T A Dellemijn, et al.
Journal of Leukocyte Biology|March 17, 2004
Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel diseaseTessa Ten Hove, F The Olle, Marloes Berkhout, et al.
Nature Medicine|April 3, 2002
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigensAnne M Dickinson, Xiao-Nong Wang, Lisbet Sviland, et al.
European Journal of Immunology|February 21, 2003
Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's diseaseAnje A te Velde, Yvette van Kooyk, Henri Braat, et al.
British Journal of Cancer|September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspectsL T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 28, 2007
Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's diseaseMarleen I Verstege, Fiebo J W ten Kate, Susanne M Reinartz, et al.
The Journal of Investigative Dermatology|February 27, 2009
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patientsJasper G van den Boorn, Debby Konijnenberg, Trees A M Dellemijn, et al.
Clinical and Experimental Immunology|October 15, 2010
Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinomaF A Vyth-Dreese, J Sein, W van de Kasteele, et al.
British Journal of Cancer|March 1, 2003
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanomaG C de Gast, D Batchelor, M J Kersten, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinomaG C de Gast, H J Klümpen, F A Vyth-Dreese, et al.
Immunology|October 10, 1998
Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphomaF A Vyth-Dreese, H Boot, T A Dellemijn, et al.
Journal of Leukocyte Biology|March 17, 2004
Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel diseaseTessa Ten Hove, F The Olle, Marloes Berkhout, et al.
Nature Medicine|April 3, 2002
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigensAnne M Dickinson, Xiao-Nong Wang, Lisbet Sviland, et al.
European Journal of Immunology|February 21, 2003
Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's diseaseAnje A te Velde, Yvette van Kooyk, Henri Braat, et al.
British Journal of Cancer|September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspectsL T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 28, 2007
Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's diseaseMarleen I Verstege, Fiebo J W ten Kate, Susanne M Reinartz, et al.
The Journal of Investigative Dermatology|February 27, 2009
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patientsJasper G van den Boorn, Debby Konijnenberg, Trees A M Dellemijn, et al.
Clinical and Experimental Immunology|October 15, 2010
Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinomaF A Vyth-Dreese, J Sein, W van de Kasteele, et al.
British Journal of Cancer|March 1, 2003
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanomaG C de Gast, D Batchelor, M J Kersten, et al.
Pageof 6